GIVE MISS CALL ON :- +91 99774 99927

CAPITALSTARS – भारत में खरीदारी के लिए बेहतर हैं ये स्‍टॉक: 15 APR 2019

The Nifty has been trading in a range-bound manner over the last two weeks and the final trading session of the week was not different. After a positive start, the bulls gave away their early advantage and the index traded volatile. However, the last hour buying helped Nifty to gain around 0.40 per cent. The index managed to close above the 13-EMA and the price action formed a small body bull candle carrying lower shadow. Two things are pretty much clear if we analyze the price action over the last two weeks. Firstly, the bulls have successfully defended the 11,549 level and, secondly, on the upside, profit-booking emerges and, as a result, the index is finding very stiff resistance in the zone of 11,710-11,760. As long as Nifty (spot) does not close below the swing low of 11,549, every dip would be a buying opportunity. However, the upside at this movement seems limited towards the zone of 11,710-11,760, which would present stiff resistance. However, the momentum is likely to kick in once the index moves out of the range of 11,550-11,760 decisively.

Dr Reddys Laboratories: The company, along with its subsidiaries, announced today that it has entered into a definitive agreement to acquire a portfolio of 42 approved, non-marketed Abbreviated New Drug Applications (ANDAs) in the US.

APL Apollo Tubes: The company has announced that it has entered into an agreement with Shankara Building Products Limited to acquire its 200,000 MTPA tube manufacturing unit based in South India for a total consideration of Rs 70 crore. The company proposes to fund this acquisition through internal accruals.

Adani Enterprises: Adani Transport Limited, a wholly-owned subsidiary of the company, has incorporated a subsidiary company, namely, Suryapet Khammam Road Private Limited, on April 12, 2019.

Suven Life Sciences: The company has announced today that it has received the US Bankruptcy Court approval of Stalking Horse agreement to buy the assets of Rising Pharmaceuticals through its joint venture partner Shore Suven Pharma Inc.

International Paper APPM: The company has informed that there would be annual outage for maintenance from April 15, 2019 to April 22, 2019 (both days inclusive) in the manufacturing facility located in Kadiyam, East Godavari district, Andhra Pradesh. The estimated loss of production would be around 200 MTs per day.

ITI: ITI has recorded a turnover of Rs 2051 crore for FY2018-19.

Eris Lifesciences: The company has notified that it has prepaid the entire loan facility obtained from Axis Bank Limited.

GMM Pfaudler: The company has executed definitive agreements for acquisition of the industrial mixing solutions division of Sudarshan Chemical Industries Ltd, Pune, on a going concern basis.

Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

CapitalStars Investment Adviser: SEBI Registration Number: INA000001647.

Leave a Reply


Ouch! There was a server error.
Retry »

Sending message...


CapitalStars FORUM